Cyclin-dependent kinase inhibitors: a survey of recent patent literature

Author： Galons Hervé   Oumata Nassima   Meijer Laurent  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.3, 2010-03, pp. : 377-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-dependent kinase inhibitors: a survey of the recent patent literature

By Pevarello Paolo   Villa Manuela  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 6, 2005-06 ,pp. : 675-703

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in the discovery and development of cyclin-dependent kinase inhibitors

By Fischer Peter M   Gianella-Borradori Athos  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 457-477

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors closer to market launch?

By Galons Hervé  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 945-963

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S.   Wang C.   Wu K.   Francis R.   Pestell R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 291-302

Bentham Science Publishers

Access to resources Recommend Favorite